Alexion Pharmaceuticals (ALXN)
|
93.66
+0.99 (+1.07%)
|
|
|
|
ALXN additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ALXN Profile
•
Exchange
NASDAQ
•
Top Holders (By Fund)
•
Top Holders (By Family)
•
Executives
Dr. Leonard Bell M.D.
Co-Founder
Chief Exec. Officer Treasurer Sec. and Director
Dr. Stephen P. Squinto Ph.D.
Co-Founder
Head of R&D and Exec. VP
Dr. Joseph A. Madri Ph.D. D.
65
Founder Director Member of Compensation Committee and Member of Pharmaceutical Compliance & Quality Committee
Mr. Vikas Sinha M.B.A. A.
CPA 49
Chief Financial Officer and Sr. VP
Mr. Patrice Coissac
Sr. VP and Pres of Alexion International SÃ rl
Co-Founder
Chief Exec. Officer Treasurer Sec. and Director
Dr. Stephen P. Squinto Ph.D.
Co-Founder
Head of R&D and Exec. VP
Dr. Joseph A. Madri Ph.D. D.
65
Founder Director Member of Compensation Committee and Member of Pharmaceutical Compliance & Quality Committee
Mr. Vikas Sinha M.B.A. A.
CPA 49
Chief Financial Officer and Sr. VP
Mr. Patrice Coissac
Sr. VP and Pres of Alexion International SÃ rl
•
Employee Count
1,008
Special Offers
Competitors
ALXN earnings
Date
Actual
Expected
Prev Yr Qtr
10/24/2012
0.60
0.47
0.37
7/25/2012
0.47
0.37
0.29
4/24/2012
0.45
0.39
0.30
